Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biostate for Immune Tolerance Induction in Pediatric Hemophilia A
NCT01445197Phase 3Terminated
- Sponsor
- CSL Limited
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of factor viii + von Willebrand factor in hemophilia A, sponsored by CSL Limited. Started Dec 2012; status: terminated.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01445197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01445197.